SIGMA LITHIUM ANNOUNCES 3Q24 RESULTS: PRODUCTION BEATS GUIDANCE, MAINTAINED LOW COSTS AT TARGET, GENERATED ROBUST $ 34 MILLION OPERATING CASH FLOW

HIGHLIGHTS

  • Sigma Lithium achieved strong operational performance at its Greentech industrial plant.
    • Produced 60,237t of Quintuple Zero Lithium Concentrate in 3Q24, higher than the 60,000t guidance 
    • Further increased shipping cadence to quasi monthly volumes sold of 22,000t
    • Sales volumes totaled 57,483t in 3Q24, increasing 9% q-on-q
    • Successfully executed Plant 1 efficiency capex revamp implementation
    • Expects 4Q24 production and sales volumes of at least 60,000t
  • Maintained one of the lowest cash unit operating costs in the industry, with CIF China averaging US$ 513/t, down from US$ 515/t in 2Q24.
  • Commercial strategy adapted to capitalize on seasonal restocking trends, weather seasonality more effectively, and outperform market price benchmarks
    • Average CIF sales price for the third quarter of US$ 820/t
  • Robust operating cash flow generation of US$ 34 million in the third quarter enabled the Company to maintain a healthy cash position of US$ 66 million at quarter-end while reducing debt by $40 million
  • Signed final development loan agreement with the BNDES, fully financing its plant 2 expansion, further de-risking construction
    • Term: 16 years with 18 months amortization grace period
    • Sub-Treasury Interest Rate: BRL 7.53%, or USD 2.5% at prevailing swap rates
  • Continued to advance Plant 2 construction with earthworks and engineering

Conference Call Information

The Company will conduct a conference call to discuss its financial results for the third quarter at 8:00 a.m. EST on Friday, November 15, 2024. Participating in the call will be Co-Chairperson and Chief Executive Officer, Ana Cabral, Chief Financial Officer, Rogerio Marchini, and Executive Vice President for Corporate Affairs and Strategic Development, Matthew DeYoe. To register for the call, please proceed through the following link Register here. For access to the webcast, please Click here.

SÃO PAULO, Nov. 15, 2024 /PRNewswire/ — Sigma Lithium Corporation SGML BVMF: S2GM34,SGML, a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon neutral, socially and environmentally sustainable lithium concentrate, announces its results for the third quarter ended September 30, 2024.

Ana Cabral, Co-Chairperson and CEO said:This quarter we achieved our production and low industry cost targets, generating robust free cash flow and demonstrating our operational resilience to lithium cycles. We also benefited from our shifted commercial strategy to navigate industry seasonality, enabling us to secure higher average realized prices compared to benchmarks.

“Over the last year we are proud to have transformed Sigma from an emerging producer into an industry leader, demonstrating the operational and financial resilience of a mature producer, with dependability and consistency. Meanwhile we have delivered on all of our climate goals, reaching  Net Zero one year in advance of our target and 27 years ahead of the industry, with our Quintuple Zero Green Lithium. We are confident that over the lithium cycles, our capabilities to execute to strategy will deliver long-term value for Sigma and all of its stakeholders“, Ms. Cabral concluded.

Key Performance Metrics for Quarter Ended September 30, 2024 (US$)


Unit

3Q24

2Q24

Sales Revenue for Shipents in Quarter

$ 000s

44,210

54,418

Provisional Price Adjustment

$ 000s

(23,316)

(8,498)

Total Sales Revenue

$ 000s

20,894

45,920

Concentrate Sold

tonnes

57,483

52,572

Concentrate Grade Sold

%

5.2 %

5.5 %

Average Reported Selling Price CIF (1)

$/t

820

1,056

Average Revenue per Tonne CIF (2)

$/t

415

894

Unit Operating Cost CIF (3)

$/t

513

515

Cash and Cash Equivalents

$ 000s

65,594

75,330

Revenues in the third quarter totaled US$44.2 million or US$20.9 million net of provisional price adjustments.

The Company has undergone a significant evolution in its commercial relationship with trading companies, strengthening commercial conditions. As a result of this change in strategy the Company concluded the final settlement of provisional sales invoices from previous quarters conducted through our traders, generating an accounting adjustment of US$(23.3) million. Importantly, these are primarily non-cash accounting closing settlements and do not have an effect on the future earnings potential of the Company.

In 3Q, Sigma Lithium maintained one of the lowest cash unit operating costs in the industry, with CIF China averaging US$ 513/t, down from US$ 515/t in 2Q24, in line with target levels.  

  • Cash unit operating costs(3) for lithium concentrate produced at the Company’s Grota do Cirilo operations in the third quarter averaged US$ 395/t (including a temporary US$25/t for mobile crushers).
  • On an FOB Vitoria(3) basis (which includes transportation and port charges) costs averaged US$449/t.
  • On a CIF China basis(3) (includes ocean freight, insurance and royalties) costs averaged US$513/t.

Robust operating cash flow generation of US$ 34 million in the third quarter enabled the Company to maintain a healthy cash position of US$ 66 million, ultimately reflecting the non-cash nature of the accounting adjustments to the quarter.

  • The Company delivered third quarter cash adjusted EBITDA(4) of US$(10.6) million. Reported EBITDA for the third quarter totaled US$(12.8) million.
  • The cash adjusted EBITDA number excludes US$0.8 million of non-recurring expenditures, primarily related to capital markets and cost initiatives, and US$1.4 million in non-cash stock-based compensation expenses.

Net income in the quarter totaled US$(25.1) million or US$(0.23) per diluted share outstanding. These reported results were affected by the aforementioned US$(23.3) million in accounting adjustments.

Operational Update

Sigma Lithium achieved strong operational performance at its Greentech industrial plant in the third quarter. Production of Sigma Lithium’s Quintuple Zero Lithium Concentrate totaled 60,237t, up 22% from 2Q24 and ahead of the 60,000t guidance. This includes numerous daily production records and periods of sustained operations above 860t per day. The Company expects 4Q24 production of lithium concentrate to reach at least 60,000 tonne.

Commercial Strategy Update

Sigma Lithium sold 57,483 tonnes of its Quintuple Zero Green Lithium concentrate in the third quarter, when its operational performance enabled it to further increase shipping cadence to quasi monthly volumes sold of 22,000t. As a result, the Company made two full 22,000t shipments during the quarter and supplemented these volumes with 13,483t sold at the Port customs warehouse.

Operational reliability and a consistent shipment pattern lowered the Company’s export credit risk, increasing the availability and lowering the interest rate of its trade finance lines. This generated direct benefits for Sigma’s commercial strategy, enabling the Company to further geographically diversify its accounts receivables, shipping to three distributors across the world: Glencore AG (Europe), Mitsubishi Corporation RtM International Pte. Ltd (Japan/ Singapore), and International Resources Holdings (UAE/Abu Dhabi).

The interest rate cost of the Company’s trade finance export credit lines decreased substantially over the year from nearly 15.5% in 4Q23 to 9.0% in 3Q24. In parallel, the amount of available export trade lines exceeded US$ 100 million in the year.

The increased financial flexibility enabled the Company to strengthen its commercial strategy and change its distribution relationship with trading companies from “traders as principals” to “traders as distributors”. This strategy shift allows Sigma to capitalize on annual restocking trends of chemical refiners, weather seasonality more effectively and outperform market price benchmarks, achieving average CIF sales price for the third quarter of US$ 820/t.

While Sigma Lithium ships and sells monthly to its trading partners, its goal is to build maximum flexibility in the final re-sale to clients to benefit from the established seasonality of refiners’ restocking periods. When combined with its superior metallurgical properties and the associated value-in-use driven cost savings to customers, Sigma believes it has positioned itself to drive superior price realizations over time.

This commercial strategy of “trader as a distributor” was not yet in place during Company’s second through seventh shipments, when trading partners served as the principals to the transaction. The accounting provisional price adjustment booked in this quarter was mainly a result of the booking of final invoice settlement and closing of these trades.

Phase 2 Expansion

Recall, on April 1, 2024, the Board of Directors announced a Final Investment Decision for the Company’s Phase 2 Greentech Plant expansion. The project is expected to add 250,000 tonnes of production capacity to the current Phase 1 operation. Importantly, the Company has already received all relevant licenses to build and operate this second Greentech Plant. 

In 3Q, Sigma Lithium initiated earthworks by completing clearing of the terrain for arid and semi-arid vegetation suppression (including fauna capture and classification) for the entire industrial project, including future phase 3 construction of production plant. Total building and commissioning are expected to occur over a 12-month period, with budgeted capex for Phase 2 of BRL492 million (approximately US$90mm at current exchange rates).

On August 29, the National Brazilian Bank for Economic and Social Development (BNDES) delivered a binding commitment to Sigma for a BRL 487mm development loan to finance this expansion.

On October 10, Sigma and the BNDES signed the final binding loan agreement, concluding the closing of the loan package. The first disbursement of the development loan is pending the Company posting bank guarantees with BNDES. This disbursement shall reimburse the capex already disbursed by the Company since first approval of the development bank loan.

The key terms and conditions of the development loan are:

  • Amount: BRL 487 million
  • Term: 192 months (16 years)
  • Interest Rate: BRL 7.53% per year (US$ at approximately 2.5% at prevailing swap rates).
  • Amortization Grace Period: 18 months – Calendarized Amortization: 174 months
  • Assets in Collateral: Not required. Development Loan shall be secured by letter of credit (“fianca bancaria”) issued by a BNDES registered financial institution.

Balance Sheet & Liquidity

Robust operating cash flow generation of US$ 34 million during the third quarter enabled the Company to maintain a healthy cash position. Sigma Lithium ended the third quarter with US$65.6 million in cash and cash equivalents.

Free cash flow in the quarter totaled US$32 million primarily related to a reduction in working capital associated with the collection of accounts receivable.

Cash generation in the third quarter enabled the Company to repay certain export credit debt, reducing outstanding trade line balances. At the end of the quarter, the Company had US$181 million in short-term and long-term debt. This included US$59 million in drawn and available, but unutilized, additional liquidity through trade finance lines.

Capital expenditures during the third quarter totaled US$2.5 million (C$3.1 million) directed towards maintenance, mining, Phase 2 expansion work, and incremental investments in the Greentech Plant. 

ABOUT SIGMA LITHIUM

Sigma Lithium SGMLSGML BVMF: S2GM34)) is a leading global lithium producer dedicated to powering the next generation of electric vehicle batteries with carbon neutral, socially and environmentally sustainable chemical-grade lithium concentrate.

Sigma Lithium is one of the world’s largest lithium producers. The Company operates at the forefront of environmental and social sustainability in the EV battery materials supply chain at its Grota do Cirilo Operation in Brazil. Here, Sigma produces Quintuple Zero Green Lithium at its state-of-the-art Greentech lithium beneficiation plant that delivers net zero carbon lithium, produced with zero dirty power, zero potable water, zero toxic chemicals and zero tailings’ dams.

Phase 1 of the Company’s operations entered commercial production in the second quarter of 2023. The Company has issued a Final Investment Decision, formally approving construction to double capacity to 520,000 tonnes of concentrate through the addition of a Phase 2 expansion of its Greentech Plant.

Please refer to the Company’s National Instrument 43-101 technical report titled “Grota do Cirilo Lithium Project Araçuaí and Itinga Regions, Minas Gerais, Brazil, Amended and Restated Technical Report” issued March 19, 2024, which was prepared for Sigma Lithium by Homero Delboni Jr., MAusIMM, Promon Engenharia; Marc-Antoine Laporte, P.Geo, SGS Canada Inc; Jarrett Quinn, P.Eng., Primero Group Americas; Porfirio Cabaleiro Rodriguez, (MEng), FAIG, GE21 Consultoria Mineral; and William van Breugel, P.Eng (the “Updated Technical Report”). The Updated Technical Report is filed on SEDAR and is also available on the Company’s website.

For more information about Sigma Lithium, visit our website 

Sigma Lithium

LinkedIn: Sigma Lithium
Instagram: @sigmalithium
X: @SigmaLithium

FORWARD-LOOKING STATEMENTS

This news release includes certain “forward-looking information” under applicable Canadian and U.S. securities legislation, including but not limited to statements relating to timing and costs related to the general business and operational outlook of the Company, the environmental footprint of tailings and positive ecosystem impact relating thereto, donation and upcycling of tailings, timing and quantities relating to tailings and Green Lithium, achievements and projections relating to the Zero Tailings strategy, achievement of ramp-up volumes, production estimates and the operational status of the Grota do Cirilo Project, and other forward-looking information. All statements that address future plans, activities, events, estimates, expectations or developments that the Company believes, expects or anticipates will or may occur is forward-looking information, including statements regarding the potential development of mineral resources and mineral reserves which may or may not occur. Forward-looking information contained herein is based on certain assumptions regarding, among other things: general economic and political conditions; the stable and supportive legislative, regulatory and community environment in Brazil; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the Company’s market position and future financial and operating performance; the Company’s estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; and the Company’s ability to operate its mineral projects including that the Company will not experience any materials or equipment shortages, any labour or service provider outages or delays or any technical issues. Although management believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that these assumptions and expectations will prove to be correct. Forward-looking information inherently involves and is subject to risks and uncertainties, including but not limited to that the market prices for lithium may not remain at current levels; and the market for electric vehicles and other large format batteries currently has limited market share and no assurances can be given for the rate at which this market will develop, if at all, which could affect the success of the Company and its ability to develop lithium operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by law. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the current annual information form of the Company and other public filings available under the Company’s profile at www.sedarplus.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Financial Tables

The Company’s independent auditor has not performed a review of the unaudited interim consolidated financial statements for the three-month period ended March 31, 2024, the six-month period ended June 30, 2024, or the interim consolidated financial statements for the nine months ended September 30, 2024 in accordance with standards established by the Canadian Institute of Chartered Accountants for a review of interim financial statements by the entity’s auditor.

Figure 1: Unaudited Income Statement Summary

Income Statement – Unaudited

Three Months Ended
September 30, 2024


Three Months Ended
September 30, 2024

($000)

CAD


USD





Sales Revenues

59,887


44,210

Provisional price adjustments

(31,612)


(23,316)

Revenue

28,275


20,894

Cost of goods sold & distribution

(39,733)


(29,232)

Gross profit

(11,458)


(8,338)

Sales expense

(535)


(392)

G&A expense

(7,163)


(5,252)

Stock-based compensation

(1,871)


(1,369)

ESG and other operating expenses

(416)


(304)

EBIT

(21,444)


(15,655)

Financial income and (expenses), net

(11,277)


(8,267)

Non-cash FX & other income (expenses), net

(278)


(163)

Income (loss) before taxes

(32,998)


(24,085)

Income taxes and social contribution

(1,247)


(1,013)

Net Income (loss) for the period

(34,246)


(25,098)





Weighted avg diluted shares outstanding

110,822


110,822





Earnings per share

($0.31)


($0.23)

Figure 2: Unaudited Balance Sheet Summary

Balance Sheet – Unaudited

Three Months Ended
September 30, 2024


Three Months Ended
September 30, 2024

($000)

CAD


USD





Assets




    Cash and cash equivalents

88,645


65,594

    Trade accounts receivable

20,122


14,889

    Inventories

22,394


16,571

    Other current assets

24,883


18,413

  Total current assets

156,044


115,467

    Property, plant and equipment

224,945


166,451

    Other non-current assets

117,459


86,915

  Total Assets

498,447


368,833





Liabilities & Shareholder Equity




    Financing and export prepayment

94,573


69,980

    Suppliers & accounts payable

57,596


42,619

    Other current liabilities

33,082


24,480

  Total current liabilities

185,251


137,080

    Financing and export prepayment

150,274


111,197

    Other non-current liabilities

15,029


11,121

  Total non-current liabilities

165,303


122,318





  Total shareholders’ equity

147,893


109,435





Total Liabilities & Shareholders’ Equity

498,447


368,833

Figure 3: Unaudited Cash Flow Statement Summary

Cash Flow Statement – Unaudited

Nine Months Ended
September 30, 2024


Nine Months Ended
September 30, 2024

($000)

CAD


USD





Operating Activities




Net income (loss) for the period

(58,302)


(42,855)





    Adjustments, including FX movements

51,351


37,346

    Interest payment on loans and leases

(587)


(426)

  Adjustments to income (loss) for the period

50,764


36,920

    Change in working capital

(197)


(143)

Net Cash from Operating Activities

(7,735)


(6,078)





Investing Activities




  Purchase of PPE

(19,377)


(14,339)

  Addition to exploration and evaluation assets

(4,228)


(3,129)

  Other

(3,900)


(2,886)

Net Cash from Investing Activities

(27,505)


(20,353)





Financing Activities




  Proceeds of loans, net

70,353


52,721

  Other

(1,521)


(1,125)

Net Cash from Financing Activities

68,832


51,596





Effect of FX

(9,350)


(8,155)

Net (decrease) increase in cash

24,242


17,010

Cash & Equivalents, Beg of Period

64,403


48,584

Cash & Equivalents, End of Period

88,645


65,594

Land Transactions:

In connection with the acquisition of additional properties located in areas of interest for Sigma Mineração S.A. (“SMSA”), an indirectly owned subsidiary of the Company, SMSA has amended the previous Credit Facility Agreement entered with Tatooine Investimentos S.A. (“Tatooine”) in 2023, increasing the amount by US$3 million, of which US$0.8 million is to be disbursed. Tatooine will continue to acquire such properties and shall grant the possession of the area to SMSA, which shall use it to continue with the Grota do Cirilo Project. This agreement and its amendments are qualified as a related party transaction under the policies of the TSXV, given that Marina Bernardini, a current officer of SMSA, has an economic interest in Tatooine.

Footnotes & Reconciliations:

To provide investors and others with additional information regarding the financial results of Sigma Lithium, we have disclosed in this release certain non-IFRS operating performance measures such as realized price per tonne, unit operating costs, EBITDA, EBITDA margin, Adjusted cash EBITDA, and Adjusted cash EBITDA margin. These non-IFRS financial measures are a supplement to and not a substitute for or superior to, the Company’s results presented in accordance with IFRS.  The non-IFRS financial measures presented by the Company may be different from non-GAAP/IFRS financial measures presented by other companies. Specifically, the Company believes the non-IFRS information provides useful measures to investors regarding the Company’s financial performance by excluding certain costs and expenses that the Company believes are not indicative of its core operating results. The presentation of these non-U.S. GAAP/IFRS financial measures is not meant to be considered in isolation or as a substitute for results or guidance prepared and presented in accordance with U.S. GAAP/IFRS.  A reconciliation of these financial measures to IFRS results is included herein.

1: Average selling price, CIF represents revenues associated with shipments invoiced during the reporting period netted out against total volume shipped. The final price may be higher or lower than the invoiced price based on future price movements.

2: Reported revenue per tonne, CIF equivalent reflects net revenues for the quarter and tonnes shipped. Given a change in accounting policy in 3Q, the Company is not realizing the ocean freight and insurance costs associated with its 3Q shipments until product has been received by the final customer. Thus, this exercise is grossing up the reported revenues for these costs to create a more peer and market comparable figure. The final price may be higher or lower than the estimated realized price based on future price movements.

Revenue Bridge  – Unaudited

Three Months Ended
September 30, 2024

$000 USD


3Q24 Invoiced Revenues – CIF

$44,550

Provisional price adjustment for shipments: 3Q24

2,607

3Q24 Revenues – CIF

$47,157

Adjustment for CIF Accounting

(2,947)

3Q24 Revenues – FOB

$44,210

Provisional price adjustment for shipments: 1Q24 – 2Q24

(15,611)

Provisional price adjustment for shipments: 3Q23 – 4Q23

(7,705)

Reported Revenues – FOB

$20,894

Adjustment for CIF Accounting

2,947

Reported Revenues – CIF

23,841



Lithium Concentrate Sales Volumes

57,483



$ / tonne


3Q24 Invoiced Price – CIF

$775

Provisional price adjustment for shipments: 3Q24

45

3Q24 Price – CIF

$820

Adjustment for CIF Accounting

(51)

3Q24 Price – FOB

$769

3. Cash unit operating costs include mining, processing, and site based general and administration costs. It is calculated on an incurred basis, credits for any capitalised mine waste development costs, and it excludes depreciation, depletion and amortization of mine and processing associated activities. When reported on an FOB basis, this metric includes road freight, and port related charges. When reported on a CIF basis it includes ocean freight, insurance and royalty costs. Royalty costs include a 2% government royalty and a 1% private royalty.

For CIF production cost analysis purposes, Sigma is considering the ocean freight costs of product that sailed in the month of reporting. However, for accounting purposes, and thus in this quarter’s reported cost of good sold and revenues, the ocean freight cost is to be recognized the moment material is delivered to the customer. Overtime, this will even out as a consistent pattern of boats are shipped and delivered, but as it is a newly adopted accounting policy, it is translating to a lower reported dollar revenue and cost for 3Q24 than what is implied by our CIF production and revenue accounting above.

4. Adjusted Cash EBITDA is a measure of recurring core earnings profile of the company. It is calculated as revenues minus cash operating and selling expenses. The calculation excludes non-cash items such as depreciation and amortization and stock-based compensation expenses as well as certain non-recurring cash expenses such as legal expenses associated with capital markets or strategic initiatives. 

Adjusted Cash EBITDA Bridge

EBITDA Bridge – Unaudited

Three Months Ended
September 30, 2024


Three Months Ended
September 30, 2024

($ 000)

CAD


USD





Sales Revenues

59,887


44,210

Provisional price adjustments

(31,612)


(23,316)

Revenues

28,275


20,894

Cost of goods sold & distribution

(39,733)


(29,232)

Gross Profit

(11,458)


(8,338)

Sales expenses

(535)


(392)

G&A expense

(7,163)


(5,252)

Stock-based compensation

(1,871)


(1,369)

ESG & other operating expenses, net

(416)


(304)

EBIT

(21,444)


(15,655)

Depreciation & Amortization

3,912


2,876

EBITDA

(17,532)


(12,779)

EBITDA (%)

-62 %


-61 %

Non-recurring expenses (1)

1,089


798

Stock-based compensation

1,871


1,369

Adjusted Cash EBITDA

(14,571)


(10,612)

Adjusted EBITDA (%)

-52 %


-51 %



(1)

Non-recurring expenses include certain legal and advisory costs and severance costs associated with ongoing productivity initiatives. 

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sigma-lithium-announces-3q24-results-production-beats-guidance-maintained-low-costs-at-target-generated-robust–34-million-operating-cash-flow-302306928.html

SOURCE Sigma Lithium Corporation

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Futures drop as Powell signals no hurry on rate cuts

(Reuters) – U.S. stock index futures fell on Friday after Federal Reserve Chair Jerome Powell said there was no need to reduce interest rates in a hurry, pushing up bond yields and pressuring rate-sensitive equities.

In a speech on Thursday, Powell pointed to ongoing economic growth, a solid job market, and inflation above the Fed’s 2% target as reasons the central bank can afford to be careful as they determine the pace and scope of rate cuts going forward.

U.S. Treasury yields rose broadly after Powell’s comments, while Wall Street’s main indexes closed lower.

“Fed Chair Powell telegraphed news that markets didn’t want to hear but news that was clearly manifest in the last CPI report, that the Fed cannot yet declare victory in its campaign to quell inflation,” said Quincy Krosby, chief global strategist for LPL Financial.

Traders increased bets that the Fed will keep rates on hold at its December meeting – pricing in a 37.6% chance, compared with 14% a month ago, according to the CME FedWatch tool. They now expect only about 73 basis points of total easing by the end of 2025, per LSEG calculations.

All three major U.S. stock indexes are set for weekly losses, as a sharp post-election rally has fizzled out with market focus shifting to the state of the economy and potential inflation risks under a second Donald Trump presidency.

Stocks of vaccine makers lost ground after the President-elect selected Robert F Kennedy Jr, who has spread misinformation on vaccines, to head the Department of Health and Human Services.

BioNTech, Moderna and Novavax all fell more than 2% in premarket trading, while Pfizer dipped 0.4%.

At 5:30 a.m. ET, Dow E-minis were down 205 points, or 0.47%, S&P 500 E-minis were down 38.5 points, or 0.64%, and Nasdaq 100 E-minis were down 185.5 points, or 0.88%.

Futures tracking the more rate-sensitive, small-cap Russell 2000 dropped 0.3%.

Megacaps stocks also fell. Nvidia edged 0.5% lower, Apple dropped 1% and Alphabet was down 0.6%

Powell’s comments come after both consumer and producer prices data this week pointed to persistent inflation.

Friday’s October retail sales data, due at 8:30 a.m. ET, will provide more signals on how consumers have coped with rising prices.

Import and export prices as well as industrial production data are also on deck through the day, while remarks from New York Fed President John Williams are also expected.

(Reporting by Lisa Mattackal in Bengaluru; Editing by Devika Syamnath)

SolarMax Technology Reports Third Quarter 2024 Financial Results

RIVERSIDE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) — SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, today reported financial results for the quarter ended September 30, 2024.

Third Quarter Highlights

  • Revenue: $6.3 million, compared with $14.3 million in Q3 2023.
  • Gross profit: $1.3 million, compared with $4.0 million in Q3 2023.
  • Total operating expense: $11.3 million, including a $7.5 million goodwill impairment relating to the China segment, compared with $3.1 million in Q3 2023.
  • Net loss: $9.6 million, or $0.21 per share, compared with net income of $1.5 million, or $0.04 per share, in Q3 2023.

David Hsu, CEO of SolarMax, stated, “Our third quarter performance reflects some of the same external factors that influenced our first half, as well as a $7.5 million goodwill impairment associated with our China segment, which has not generated any revenue since 2022. The revenues in the three and nine months ended September 30, 2023 reflected an unusual surge in demand as residential customers accelerated their solar system purchases to take advantage of favorable rebate conditions before regulatory changes in California, which made purchases of residential solar systems less attractive to homeowners, took effect in April 2023. This created a temporary boost in our 2023 numbers. Since we completed these orders in 2023, our 2024 revenues reflected a significant drop from the 2023 revenues. Additionally, our revenues were impacted by the increased borrowing costs associated with higher interest rates, which resulted in a decline in consumer investment in solar across the industry. Additionally, in the three months ended September 30, 2024, we recognized the expense associated with the termination of forfeiture provisions of restricted stock of approximately $1.3 million and the impairment of goodwill on our balance sheet in China of approximately $7.5 million which resulted in higher operating expenses by $8.8 million. In the nine months ended September 30, 2025, we incurred stock-based compensation expenses of $18.6 million resulting from stock options becoming non-forfeitable as a result of the completion of our initial public offering. Although these charges significantly impacted the results of our operations for the quarter, they were a one-time, non-cash event.”

“Despite the short-term challenges, we are focused on looking to execute our long-term growth strategy, and we continue to see underlying demand for our solar solutions,” continued Hsu. “Efforts to significantly expand our commercial solar project portfolio are well underway, and we anticipate these projects will play an increasing role in our revenue growth in the quarters ahead. However, we cannot predict the effect, if any, that federal policies relating to renewable energy will affect the market for solar systems.”

About SolarMax Technology Inc.

SolarMax, based in California and founded in 2008, is a leader within the solar and renewable energy sector focused on making sustainable energy both accessible and affordable. SolarMax has established a strong presence in southern California. SolarMax is looking to generate growth with strategic initiatives that aim to scale commercial solar development services and LED lighting solutions in the US while expanding its residential solar operations. For more information, visit www.solarmaxtech.com.

Any information contained on, or that can be accessed through, our website or any other website or any social media is not a part of this press release.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements are subject to risk and uncertainties, including, but not limited to, including but not limited to the Company’s ability to develop its commercial solar business and to be accepted as a provider of commercial solar systems in the United States, and its ability to translate its experience in China, where it has not completed an installation since 2021, to the current United States market, any changes in governmental policies relating to renewable energy and those described in “Cautionary Note on Forward-Looking Statements” “Item 1A. Risk Factors,” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 16, 2024 and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s report on Form 10-Q for the quarter ended September 30, 2024, which was filed with the SEC on November 14, 2024. SolarMax undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

Contact:
For more information, contact:
Stephen Brown, CFO
(951) 300-0711


© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Asia And Europe Markets Mixed; Fed's Hawkish Comments Boost Dollar – Global Markets Today While US Slept

On Thursday, Nov. 14, U.S. markets ended lower after Fed Chair Jerome Powell dampened hopes for an interest rate cut, citing steady economic growth, a strong job market, and persistent inflation. Traders reduced bets on a December cut, leading to declines in the Dow, S&P 500, and Nasdaq.

Powell’s remarks followed data showing a rise in producer prices for October, slightly higher than expected.

Related: Powell’s Hawkish Remarks Shake Markets: Stocks Fall, Dollar Rockets, Bitcoin Dips

Economic data showed that U.S. jobless claims fell by 4,000 to 217,000 for the week ending Nov. 9, beating estimates of 223,000. Producer prices increased by 0.2% in October, matching market expectations after a revised 0.1% rise in September.

The majority of S&P 500 sectors fell, led by consumer discretionary, industrials, and healthcare. However, tech and energy stocks ended higher.

The Dow Jones Industrial Average was down 0.47% and closed at 43,750.86, the S&P 500 declined 0.50% to 5,949.17, and the Nasdaq Composite slid 0.64% to finish at 19,107.65.

Asia Markets Today

  • On Friday, Japan’s Nikkei 225 declined 0.35% and ended the session at 38,637.50, led by gains in the Warehousing, Shipbuilding, and Trading sectors.
  • Australia’s S&P/ASX 200 rose 0.74% and ended the day at 8,285.20, led by gains in the Utilities, Gold, and Financials sectors.
  • India Markets were closed for the Guru Nanak Jayanti holiday.
  • China’s Shanghai Composite declined 1.45% to close at 3,330.73, and the Shenzhen CSI 300 fell 1.75%, finishing the day at 3,968.83.
  • Hong Kong’s Hang Seng slipped 0.09% and closed the session at 19,426.34.

Eurozone at 05:30 AM ET

  • The European STOXX 50 index was down 0.23%.
  • Germany’s DAX gained 0.14%.
  • France’s CAC fell0.04%.
  • UK’s FTSE 100 index traded higher by 0.02%.
  • European stocks were mixed after weak U.K. growth data, higher French inflation, and hawkish Fed remarks.

Commodities at 05:30 AM ET

  • Crude Oil WTI was trading lower by 1.35% at $67.78/bbl, and Brent was down 1.28% at $71.63/bbl.
  • Oil prices declined, heading for a weekly loss amid concerns over weakening Chinese demand and fewer anticipated U.S. rate cuts. Lower refinery output and slowing factory growth in China added pressure.
  • Natural Gas declined 2.44% to $2.717.
  • Gold was trading higher by 0.04% at $2,573.80, Silver gained 0.16% to $30.610, and Copper rose 1.6% to $4.1420.

US Futures at 05:30 AM ET

Dow futures decreased 0.44%, S&P 500 futures were down 0.63%, and Nasdaq 100 futures fell 0.88%.

Forex at 05:30 AM ET

  • The U.S. Dollar Index declined 0.15% to 106.51, USD/JPY was down 0.60% at 155.30, and USD/AUD slid 0.25% to 1.5453.
  • The U.S. dollar hit near one-year highs after Fed Chair Powell’s hawkish comments boosted Treasury yields, pressuring equities. The dollar’s surge weighed on the euro, gold, and oil prices.

Image via Pexels

Market News and Data brought to you by Benzinga APIs

Wall Street ponders a potential debt reckoning from Trump spending plans: Morning Brief

This is The Takeaway from today’s Morning Brief, which you can sign up to receive in your inbox every morning along with:

Now that Donald Trump has been elected to a second term as president, investors have had to reckon with paradigm shifts to their positioning, from tariffs to “DOGE.”

There’s also the bogeyman of the ballooning debt that the US will take on if Trump enacts his campaign promises. According to an analysis by the nonpartisan Committee for a Responsible Federal Budget, Trump’s plans will boost the debt by $7.75 trillion.

While that’s not a “today problem” for investors, they’re still grappling with what that increase could mean down the road.

“I think markets tend to react to the shark closest to the boat,” Rick Rieder, chief investment officer for fixed income at BlackRock, told me at the Yahoo Invest conference this week. “The shark on the debt dynamic is not going to be next to the boat in January or February, but it is going to get next to the boat sometime. I don’t know if it’s the latter part of 2025 or the beginning of 2026, unless they address the size of the spending dynamics, the amount of debt we’re issuing, and then obviously inflation relative to that.”

Rieder laid out a scenario where “bond vigilantes” could attack. Essentially, if regular buyers of government Treasurys decide that Trump’s fiscal policies are inflationary, they could stage a strike, or sell en masse, driving up yields. That, in turn, would increase debt servicing costs for the US government and create a ripple effect throughout markets and the economy.

Of course, US debt has been rising for years, and the federal government hasn’t had a surplus (with revenue exceeding spending) since the brief window between the end of the Clinton administration and the start of the George W. Bush administration. And markets have mostly looked the other way.

John Stoltzfus of Oppenheimer invoked Bill Gross’s famous “cleanest dirty shirt” comparison when explaining why: “The US stands out because of our accountability, our transparency, governance, and also our capability to innovate and the size of our economy,” he said in a recent interview.

That said, Stoltzfus, like most market participants, says federal debt will become a problem … eventually. For now, it’s more a discussion point than an economic obstacle.

Julie Hyman is the co-host of Market Domination on Yahoo Finance. You can find her on social media @juleshyman.

Digihost Announces $31.4M in YTD Revenue, Representing a 104% YOY Increase

HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company“) (Nasdaq / TSXV:DGHI), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide a summary of the Company’s unaudited financial results for the third quarter ended September 30, 2024 (all amounts in U.S. dollars, unless otherwise indicated) and a 2024 year-to-date update on its operations. The Company’s unaudited consolidated financial statements and management’s discussion and analysis (“MD&A“) for the nine-month period ended September 30, 2024 have been filed and made accessible under the Company’s continuous disclosure profile on SEDAR+ at www.sedarplus.ca and also on EDGAR at www.sec.gov/edgar.

Comparative Financial Highlights for the Three-Month Period Ended and as at September 30, 2024:

  • Revenue of $9.2 million for the three-month period ended September 30, 2024, compared to $5.4 million for the three-month period ended September 30, 2023, representing an increase of 71%, as the Company has significantly diversified its revenue verticals through various colocation agreements and the sale of energy;
  • Digital currencies of $4.9 million, and total current assets of $6.7 million;
  • The Company ended the quarter with a positive Net Working Cash flow of approximately $1 million.

Comparative Financial Highlights for the Nine-Month Period Ended September 30, 2024:

  • Revenue of $31.4 million for the nine-month period ended September 30, 2024, compared to $15.3 million for the nine-month period ended September 30, 2023, representing an increase of 104%, as the Company has significantly diversified its revenue verticals through various colocation agreements and the sale of energy;
  • Revenue from the sale of energy increased by approximately 128% compared to the nine-month period ended September 30, 2023;
  • EBITDA* of $5.5 million for the nine months ended September 30, 2024. This represents a nearly 350% increase compared to the nine-month period ended September 30, 2023.
(U.S.$ in thousands except share and per share data) Nine Months Ended
  September 30,
2024
September 30,
2023
Revenue from Digital Currency Mining 10,318   13,522  
Revenue from Colocation Services 10,714    
Revenue from Sale of Electricity 6,283    
Revenue from Sale of Energy 4,050   1,779  
Total Revenue   15,332  
     
Cost of Revenue (25,511)   (10,515)  
Depreciation and Amortization (11,790)   (9,732)  
Miner Lease & Hosting Agreement   (791)  
Gross loss (5,936)   (5,707)  
     
General and administrative and other expenses (3,091)   (3,727)  
Foreign exchange 1,127   (101)  
Gain on disposition of cryptocurrencies 229   802  
Change in FV of loan payable (20)   (144)  
Other Income (expense) 14   90  
Change in fair value – Miner Lease Agreement   (268)  
Share based compensation (1,267)   (1,217)  
Gain on Revaluation of Digital Currencies 251   23  
     
Operating loss (8,692)   (10,250)  
Revaluation of warrant liabilities 2,380   (1,756)  
Net financial expenses (22)   (195)  
Net income (loss) before income taxes (6,334)   (12,200)  
Income tax expense    
Net income (loss) for the year (6,334)   (12,200)  
Foreign currency translation adjustment (1,091)   104  
Revaluation of digital currency, net of tax    
Total comprehensive loss for the year (7,424)   (12,096)  
Basic and diluted income (loss) per share
Weighted average number of subordinate voting shares outstanding – diluted
(0.21)
29,929,917
  (0.43)
28,525,059
 


* EBITDA – NON-IFRS MEASURE

EBITDA is a non-IFRS financial measure and should be read in conjunction with and should not be viewed as an alternative to or replacement of measures of operating results and liquidity presented in accordance with IFRS. Readers are referred to the reconciliations of non-IFRS measures included in the Company’s MD&A and in the table below.

The following table provides a reconciliation of net income to EBITDA for the fiscal periods ended September 30, 2024 and 2023:

  Nine months ended
    2024   2023
    $   $
Income (loss) before other items   (6,333,643)   (12,200,349)
Taxes and Interest   22,041   194,971
Depreciation   11,789,865   9,732,088
EBITDA    5,478,263   (2,273,290)
         


Operations Update

Presently, Digihost’s consolidated operating capacity across its three sites represents approximately 100MW of available power, and Digihost is mining at a hash rate of 3 EH/s. The Company experienced significant growth within its colocation services segment, which now serves as the Company’s largest revenue segment. During the quarter, the Company completed maintenance at its flagship North Tonawanda power plant to increase long-term efficiency. The Company expects to bring the plant back to full operational power in the fourth quarter of 2024.

Outlook

Digihost remains focused on expanding its power portfolio and maximizing the optimal use of its energy resources. The Company has now produced more revenue year-over-year through its colocation services than digital mining, and it expects to continue to expand the portion of its revenue from colocation services in the future. Through colocation with some of the world’s largest mining companies, the Company will have access to the latest generation of miners, retaining its cutting-edge efficiency and low cost of mining production without the downside associated with mining outright (e.g., significant capital expenditure outlay and accelerated depreciation). This strategy lets the Company focus its investment and assets upstream on power development and production. This strategy is designed to aid the Company in expanding its MW footprint significantly in 2025, with the goal of achieving an expected hash rate of 6-7 EH in 2026.

Simultaneously, with the growth of the Company’s power portfolio, the Company looks forward to converting portions of its existing asset base into tier-3 data center infrastructure in the coming months. Leveraging its established electrical infrastructure, regulatory expertise, and customer relationships, Digihost anticipates that this conversion will reduce both costs and timelines relative to industry standards, providing a distinct competitive edge.

About Digihost

Digihost is an innovative energy infrastructure company that develops cutting-edge data centers to drive the expansion of sustainable energy assets.

For further information, please contact:

Digihost Investor Relations
www.digihostpower.com
T: 888-474-9222
Email: ir@digihostpower.com

Cautionary Statement

Trading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Except for the statements of historical fact, this news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) that are based on expectations, estimates and projections as at the date of this news release and are covered by safe harbors under Canadian and United States securities laws. Forward-looking information in this news release includes information about potential further improvements to profitability and efficiency across mining operations, including as a result of the Company’s expansion efforts, potential for the Company’s long-term growth, and the business goals and objectives of the Company. Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to: future capital needs and uncertainty of additional financing; share dilution resulting from equity issuances; risks relating to the strategy of maintaining and increasing Bitcoin holdings and the impact of depreciating Bitcoin prices on working capital; development of additional facilities and installation of infrastructure to expand operations may not be completed on the timelines anticipated by the Company, or at all; ability to access additional power from the local power grid; a decrease in cryptocurrency pricing, volume of transaction activity or generally, the profitability of cryptocurrency mining; further improvements to profitability and efficiency may not be realized; development of additional facilities to expand operations may not be completed on the timelines anticipated by the Company; ability to access additional power from the local power grid; an increase in natural gas prices may negatively affect the profitability of the Company’s power plant; the digital currency market; the Company’s ability to successfully mine digital currency on the cloud; the Company may not be able to profitably liquidate its current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on the Company’s operations; the volatility of digital currency prices; and other related risks as more fully set out in the Annual Information Form of the Company and other documents disclosed in the Company’s filings at www.sedarplus.ca and www.SEC.gov/EDGAR. The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about: the current profitability in mining cryptocurrency (including pricing and volume of current transaction activity); profitable use of the Company’s assets going forward; the Company’s ability to profitably liquidate its digital currency inventory as required; historical prices of digital currencies and the ability of the Company to mine digital currencies on the cloud will be consistent with historical prices; the ability to maintain reliable and economical sources of power to run its cryptocurrency mining assets; the negative impact of regulatory changes in the energy regimes in the jurisdictions in which the Company operates; and there will be no regulation or law that will prevent the Company from operating its business. The Company has also assumed that no significant events occur outside of the Company’s normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainties therein. The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.


Market News and Data brought to you by Benzinga APIs

Trump's Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives Borrowing Costs To 25-Year Low

In the wake of Donald Trump’s recent election victory, companies are rushing to tap into the US bond market, taking advantage of favorable conditions. Firms such as Caterpillar Inc. CAT, Gilead Sciences Inc. GILD, and Goldman Sachs Group Inc. GS have collectively raised over $50 billion in the past week.

What Happened: The surge in corporate borrowing is driven by a rally in credit and equity markets, which has pushed borrowing costs to historic lows. Investors are optimistic about potential tax cuts boosting profits, leading to a decrease in corporate borrowing costs relative to U.S. Treasuries, reported The Financial Times on Friday. The U.S. investment-grade bond spreads were at 0.8 percentage points late Thursday, nearing their lowest since 1998.

Banks have been quick to capitalize on these conditions, with significant activity in the financial sector.

See Also: Amid Appointment Of Elon Musk, Vivek Ramaswamy, Team Trump Now Reportedly Planning To Overhaul Military Posts

Why It Matters: The bond market has been experiencing heightened volatility, as evidenced by the MOVE index reaching its highest level in over a year ahead of the U.S. election.

Following Trump’s election, bond yields have continued to rise, complicating the Federal Reserve’s efforts to ease borrowing costs. The 10-year Treasury yield reached 4.34%, influenced by speculation surrounding Trump’s fiscal agenda.

Trump’s reelection has had a profound impact on financial markets, with the S&P 500 Index reaching new all-time highs since the election. This contrasts the volatility experienced by the emerging market stocks dropping to levels last seen in mid-September.

Read Next:

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Image via Shutterstock

Market News and Data brought to you by Benzinga APIs

Protein Therapeutics Market Size to be Worth USD 549.4 billion by 2031, at a CAGR of 6.3% | Transparency Market Research, Inc.

Wilmington, Delaware, United States, Transparency Market Research Inc. -, Nov. 15, 2024 (GLOBE NEWSWIRE) — The protein therapeutics market (단백질 치료제 시장) was valued at US$ 318.4 billion in 2022. A CAGR of 6.3% is predicted from 2023 to 2031, reaching more than US$ 549.4 billion by 2031.  A broader range of diseases can be treated with novel protein therapeutics based on research in proteomics, genomics, and systems biology. Technological advances, such as glycoengineering and protein engineering, are making it possible to create biologics that are less immunogenic and have better pharmacokinetics.

Genetic disorders could be treated more effectively by integrating gene therapy and protein therapeutics. In addition, more complex diseases may benefit from combination therapies. As bioprocessing and manufacturing technologies improve, protein therapeutics could be made more affordable and scalable, thereby improving access to these treatments.

Treatment for rare diseases may benefit greatly from protein therapeutics, which are particularly effective in targeting and directing interventions. Cancer and other immune-related disorders may benefit further from immunotherapies, including monoclonal antibodies and other protein-based approaches. By enhancing drug delivery technologies, protein therapeutics can be made more bioavailable, administered less frequently, and improved in compliance with medical guidelines.

Request to Sample PDF of this Strategic Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2035


Rare diseases are increasingly being treated with protein therapeutics. Protein-based therapies and advances in molecular studies have contributed to this trend. Oncology continues to emphasize immunotherapies, especially monoclonal antibodies. The market for protein therapeutics is experiencing significant growth in immuno-oncology targets and combination therapies. Growing demand for biosimilar drugs, including protein therapeutics that are similar to approved biologics, has been observed in the market for biosimilar. In addition to the expiration of biologic patents and potential cost savings, this trend is also driven by the expiration of biologic patents.

Key Findings of the Market Report

  • In 2022, monoclonal antibodies held the largest share of the global protein therapeutics market.
  • Based on application, cancer was the most important segment of the global protein therapeutics market in 2022.
  • North America is expected to experience rapid growth in the near future.
  • In 2022, Asia Pacific experienced robust growth for protein therapeutics in the market.

Global Protein Therapeutics Market: Growth Drivers

  • In recent years, chronic diseases such as cancer, diabetes, and autoimmune diseases have driven demand for protein therapeutics and the development of targeted biological therapies.
  • Protein therapeutics are becoming more complex and effective with advances in biotechnology, such as recombinant DNA, genetic engineering, and protein expression systems. A monoclonal antibody is a highly specific protein therapeutic that targets a specific disease pathway.
  • Traditional small-molecule drugs often have more side effects than this targeted approach. Protein therapeutics have become increasingly popular due to the trend towards personalized medicine.
  • Public and private investments in the biopharmaceutical industry support the development and commercialization of protein therapeutics. Protein therapeutics are gaining popularity due to aging populations, biologic awareness, and quality of life concerns.
  • Research and development are vital to discovering and bringing new protein therapeutics to market for pharmaceutical companies and biotechnology companies. New therapeutic targets are being developed while existing protein-based drugs are being improved.
  • Beyond traditional areas of oncology, protein therapeutics are discovering new applications. In addition to treating various diseases, such as infectious diseases, rare genetic disorders, and neurological conditions, these drugs are also being investigated to treat various diseases.

Global Protein Therapeutics Market: Regional Landscape

  • North America will dominate the market for protein therapeutics. Several key players and new treatments are driving the growth of the protein therapeutics industry in North America. Protein therapeutics are crucial to treating diseases of chronic nature, such as diabetes, cancer, and autoimmune problems, which have become increasingly prevalent in recent times.
  • Recent advances in biotechnology have enabled the development and production of new and more complex protein therapeutics, especially in genetic engineering and protein expression systems. Research and development investments in protein-based drugs continue to be heavily made by pharmaceutical and biotechnology companies in North America.
  • Regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and Health Canada, have provided clear pathways for the review and approval of protein therapeutics.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2035

Global Protein Therapeutics Market: Key Players

The global protein therapeutics market is fragmented, with the presence of large number of players. Companies are focusing on investment in R&D and collaborations to increase market share.

  • Thermo Fisher Scientific Inc.
  • Genzyme Corporation (Sanofi)
  • AbbVie Inc.
  • Sanofi
  • Leadiant Biosciences
  • Takeda Pharmaceutical Company Limited
  • Amicus Therapeutics
  • Bayer AG
  • Bristol-Myers Squibb
  • Daiichi Sankyo Company
  • Abbott
  • Sanofi

Key Developments

  • In April 2022, Plexium and AbbVie partnered to develop and commercialize targeted protein degradation therapeutics for neurological diseases. AbbVie and Plexium develop novel therapies against historically challenging drug targets by leveraging AbbVie’s neuroscience expertise. AbbVie will select additional research and development programs based on preclinical research activities for the collaboration targets.
  • In November 2023, the United States-South Korean biotech company Orum Therapeutics received $180 million from Bristol Myers Squibb (BMS) to develop an antibody-drug conjugate (ADC) for treating blood cancer.

Global Protein Therapeutics Market: Segmentation

By Product

  • Monoclonal Antibodies
  • Enzyme Replacement Therapy
  • Cytokines
  • Interferons
  • Interleukins
  • Growth Factors
  • Fusion Proteins
  • Anti-coagulants
  • Bone Morphogenetic Proteins (BMPs)
  • Hormones
  • Others (engineered protein scaffolds, etc.)

By Application

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Genetic Disorders

By Route of Administration

  • Injectable Proteins
  • Oral Proteins

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latina America

Drive Your Growth Strategy: Purchase the Report for Key Insights! https://www.transparencymarketresearch.com/checkout.php?rep_id=2035&ltype=S

Have a Look at Related Reports of Pharmaceutical Domain:

Transplant Diagnostics Market (移植診断市場)  – The global transplant diagnostics market was projected to attain US$ 1.2 billion in 2022. It is anticipated to garner a 7.7% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 2.3 billion by 2031.

Glaucoma Treatment Market (سوق علاج الجلوكوما) – The glaucoma treatment market was valued at US$ 6.3 billion in 2022. A CAGR of 4.3% is projected from 2023 to 2031, reaching US$ 9.1 billion.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube


Primary Logo

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.